BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21732774)

  • 1. Immunohistochemistry of melanocytic proliferations.
    Prieto VG; Shea CR
    Arch Pathol Lab Med; 2011 Jul; 135(7):853-9. PubMed ID: 21732774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of immunohistochemistry in melanocytic lesions.
    Prieto VG; Shea CR
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():1-10. PubMed ID: 18976412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of COX-2 protein expression in melanocytic nevi in children].
    Kubus M; Andrzejewska E; Nejc D; Kobos J; Taran K
    Pol Merkur Lekarski; 2013 Aug; 35(206):82-4. PubMed ID: 24052986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic mimics of malignant melanoma.
    Bsirini C; Smoller BR
    Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
    Rodić N; Zampella J; Sharma R; Burns KH; Taube JM
    J Cutan Pathol; 2015 Nov; 42(11):807-14. PubMed ID: 26239102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
    Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
    Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocytic lesions - Staying out of trouble.
    Brenn T
    Ann Diagn Pathol; 2018 Dec; 37():91-102. PubMed ID: 30312883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of p16 immunohistochemical stain to help differentiate inflamed melanocytic nevi from metastatic melanoma in the setting of immunotherapy.
    Adelman M; Lyons AB; Seale L; Friedman BJ
    J Am Acad Dermatol; 2020 Apr; 82(4):e117-e119. PubMed ID: 31765681
    [No Abstract]   [Full Text] [Related]  

  • 11. The Four-color FISH probe in the diagnosis of melanocytic lesions.
    Boi S; Leonardi E; Fasanella S; Cantaloni C; Micciolo R
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1235-6. PubMed ID: 20236383
    [No Abstract]   [Full Text] [Related]  

  • 12. Principles of dermatoscopy of pigmented skin lesions.
    Stolz W; Semmelmayer U; Johow K; Burgdorf WH
    Semin Cutan Med Surg; 2003 Mar; 22(1):9-20. PubMed ID: 12773010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
    Bergman R; Azzam H; Sprecher E; Manov L; Munichor M; Friedman-Birnbaum R; Ben-Itzhak O
    J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?
    Zembowicz A; Scolyer RA
    Arch Pathol Lab Med; 2011 Mar; 135(3):300-6. PubMed ID: 21366452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct expression profile separates Turkish and Australian melanocytic naevi.
    Fox C; Schaider H; Akalin T; Turkmen M; Sturm R; Lambie D; Karaarslan IK; Soyer HP; Ozdemir F; Gabrielli B
    Histopathology; 2016 Jul; 69(1):151-4. PubMed ID: 26599517
    [No Abstract]   [Full Text] [Related]  

  • 16. A quantitative proteomic analysis of FFPE melanoma.
    Byrum S; Avaritt NL; Mackintosh SG; Munkberg JM; Badgwell BD; Cheung WL; Tackett AJ
    J Cutan Pathol; 2011 Nov; 38(11):933-6. PubMed ID: 21883366
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on fluorescence in situ hybridization in melanoma: state of the art.
    Gerami P; Zembowicz A
    Arch Pathol Lab Med; 2011 Jul; 135(7):830-7. PubMed ID: 21732770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass Spectrometry Imaging Can Distinguish on a Proteomic Level Between Proliferative Nodules Within a Benign Congenital Nevus and Malignant Melanoma.
    Lazova R; Yang Z; El Habr C; Lim Y; Choate KA; Seeley EH; Caprioli RM; Yangqun L
    Am J Dermatopathol; 2017 Sep; 39(9):689-695. PubMed ID: 28248717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
    Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
    Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.